Skip to content

Long-term outcomes of endoscopic full-thickness resection plus laparoscopic regional lymph node dissection versus conventional gastrectomy for cT1bN0 early gastric cancer: a prospective real-world study

Long-term outcomes of endoscopic full-thickness resection plus laparoscopic regional lymph node dissection versus conventional gastrectomy for cT1bN0 early gastric cancer: a prospective real-world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120034
Enrollment
Unknown
Registered
2026-03-09
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Dual-Endoscopy Combined Surgery Group for Early Gastric Cancer:None

Sponsors

Peking University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age between 18 and 80 years; 2.Pathologically confirmed gastric adenocarcinoma via biopsy; 3.Staged as Stage IA according to the 8th Edition TNM Classification of the AJCC (American Joint Committee on Cancer); 4.Tumor size 2 cm away from both the esophagogastric junction (EGJ) and the pylorus; 5.ECOG performance status of 0 or 1.

Exclusion criteria

Exclusion criteria: 1.Patients who meet the indications for endoscopic resection, specifically: (1) Differentiated adenocarcinoma, ulcer-negative (UL0), macroscopic mucosal cancer (cT1a), regardless of lesion diameter; (2) Differentiated adenocarcinoma, ulcer-positive (UL1), macroscopic mucosal cancer (cT1a), with a lesion diameter <= 3 cm; (3) Undifferentiated adenocarcinoma, ulcer-negative (UL0), macroscopic mucosal cancer (cT1a), with a lesion diameter <= 2 cm. 2.Patients with concurrent malignancies (other co-existing tumors); 3.Patients who have received preoperative chemoradiotherapy or undergone other upper abdominal surgeries (excluding laparoscopic cholecystectomy); 4.Patients with multiple gastric lesions, cancers in other organs, or other conditions that do not meet the study requirements.

Design outcomes

Primary

MeasureTime frame
Surgical Complications;

Secondary

MeasureTime frame
R0 Resection Rate;3-year Disease-Free Survival (DFS) Rate;

Countries

China

Contacts

Public ContactWu Qi; Li Ziyu

Peking University Cancer Hospital

wuqi1973@hsc.pku.edu.cn+86 139 0101 3168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026